Inhibitor Therapeutics, Inc. Current Federal Tax Expense (Benefit)
Inhibitor Therapeutics, Inc. (INTI) reported Current Federal Tax Expense (Benefit) of $22.85 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. current federal tax expense (benefit) for fiscal 2022 was $22.85K.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2022-12-31 | $22.85K 10-K · filed 2024-03-29 |